MediChain

MediChain

Created using Figma
MediChain is een medisch big data-platform. Het biedt patiënten de mogelijkheid hun eigen gegevens in een geschikt geografisch domein op te slaan en toegang te geven tot artsen en specialisten, ongeacht het betalernetwerk of de gebruikte EMR.
mrt., 2018
apr., 2018
100% voltooid
Opgehaald geld - geen gegevens
Harde dop 40 000 000.00 USD
past
  • 1 MCU
    =
    1 USD
Details token
Ticker
MCU
Geaccepteerde valuta's
ETH, BTC, USD, LTC, BCH, ZEC, DASH, NEO, FIAT, VARIOUS
Bedrijfsgegevens
Geregistreerd land
United Kingdom
aanvullende details
Platform
Ethereum
KYC
Ja
Categorieën
Platform, Gezondheid, Slim contract, Big Data

Over MediChain

Levens redden met blockchain

Medichain is een medisch big data-platform. Het stelt patiënten in staat hun eigen gegevens buiten de keten op te slaan in een geschikt geografisch domein en geeft overal toegang tot artsen en specialisten, ongeacht het betalernetwerk of de gebruikte EMR. MediChain is uniek in medische dossiers voor zover het niet alleen een geduldige oplossing biedt, maar de waarde van de gegevens als big data gebruikt "bij de eerste tekst boven de video. & Nbsp;

Kenmerken

MediChain is uniek in medische dossiers, omdat het niet alleen een oplossing voor de patiënt biedt, maar de waarde van de gegevens als big data gebruikt.

% naam% Roadmap

  • Q1 2018

  • Public MVP
    System live and scaled on Rackspace servers
    Research
    Scientist program, 10+ rolling grants to get high quality data
    Pharma
    Outreach program to determine data needs
    Stakeholder
    Data stakeholder program starts to ensure buy-in
    HIPAA & FDA
    Compliance completed
    Research
    Outreach program 1-3 grants gets best data
    Team Growth
    Headhunting world class talent in line with needs
    Talent Search
    Attracting great talent. Includes hackathons
    Partner Creation
    Research and build high value data partners
    Pharma
    Partnerships developing 10-15 companies
  • Public MVP

  • MedRec system live and scaled on rackspace servers
  • Q2 2018

  • Research
    Scientist Program, 3-5 grants to get high value data
    EHR/EMR
    Integration between EMR and MediChain completed
    Analysis
    Ongoing operational needs analysis
  • 2018

  • Public MVP
    Research
    Pharma
    Stakeholder
    HIPAA & FDA
    Research
    Team Growth
    Talent Search
    Partner Creation
    Pharma
    Research
    EHR/EMR
    Analysis
    Big Data
    Security
    Technology
    Big Data
    Strategic Review
    Talent Development
  • Lees verder
  • Research

  • Scientist program, 10+ rolling grants to get high quality data
  • Q3 2018

  • Big Data
    Data 1TB+. Tech upgrade to handle next petabyte
    Security
    Q3: Additional white hat and tiger teams
    Technology
    Shift to fast parallel blockchains for different WHO data sets
  • Pharma

  • Outreach program to determine data needs
  • Q4 2018

  • Big Data
    Data PB+. Tech Upgrade to handle next exabyte
    Strategic Review
    Maximising growth, value and social impact
    Talent Development
    Funnel, bring in and develop top talent
  • Stakeholder

  • Data stakeholder program starts to ensure buy-in
  • Q1 2019

  • Research
    Scientist program, 5-10 grants to get high value data
    API Development
    Develop API for third party integration, promotion and support
    Data Hackathons
    Promote high profile medical hackathons
  • 2019

  • Research
    API Development
    Data Hackathons
    Pharma
    Partner Creation
    Publications
    Standards
    Big Data
    Pharma
    Symposium
    Technology
    EHR/EMR
    Smartcard
    Strategic Review
    Big Data
    Symposium
    Pharma
  • HIPAA & FDA

  • Compliance completed
  • Q2 2019

  • Pharma
    Partnerships closed with 5-10 companies
    Partner Creation
    Research and build high value data partners
    Publications
    Target for first publications with epidemiological trends
  • Research

  • Outreach program 1-3 grants gets best data
  • Q3 2019

  • Standards
    Formation of Medical Blockchain standards group
    Big Data
    Tech EB+ Upgrade to handle next 10EBs
    Pharma
    Partnerships closed with 1-3 companies
  • Team Growth

  • Headhunting world class talent in line with nee
  • Q4 2019

  • Symposium
    Annual Big Data IT & Science symposium for MediChain
    Technology
    Upgrade to version 2.0 for scale and security
    EHR/EMR
    Systems start to acquire patient data to MediChain
  • Talent Search

  • Attracting great talent. Includes hackathons
  • Q1 2020

  • Smartcard
    Initiation of Doctor and Patient Smartcard program
  • Partner Creation

  • Research and build high value data partne
  • Q2 2020

  • Strategic Review
    Maximising growth, value and social impact
  • Pharma

  • Partnerships developing 10-15 companies
  • Q3 2020

  • Big Data
    Data 10EB+. Tech Upgrade to handle next stage
  • Research

  • Scientist Program, 3-5 grants to get high value data
  • Q4 2020

  • Symposium
    Aims to be the leading data provider in the industry
    Pharma
    Partnerships close with 10-20 companies
  • EHR/EMR

  • Integration between EMR and MediChain complet
  • Analysis

  • Ongoing operational needs analysis
  • Big Data

  • Data 1TB+. Tech upgrade to handle next petabyte
  • Security

  • Q3: Additional white hat and tiger teams
  • Technology

  • Shift to fast parallel blockchains for different WHO data sets
  • Big Data

  • Data PB+. Tech Upgrade to handle next exabyte
  • Talent Development

  • Funnel, bring in and develop top talent
  • Research

  • Scientist program, 5-10 grants to get high value data
  • API Development

  • Develop API for third party integration, promotion and support
  • Data Hackathons

  • Promote high profile medical hackathons
  • Pharma

  • Partnerships closed with 5-10 companies
  • Partner Creation

  • Research and build high value data partners
  • Publications

  • Target for first publications with epidemiological
  • Standards

  • Formation of Medical Blockchain standards group
  • Big Data

  • Tech EB+ Upgrade to handle next 10EBs
  • Pharma

  • Partnerships closed with 1-3 companies
  • Symposium

  • Annual Big Data IT & Science symposium for MediChain
  • EHR/EMR

  • Systems start to acquire patient data to MediChain
  • Smartcard

  • Initiation of Doctor and Patient Smartcard program
  • Strategic Review

  • Maximising growth, value and social impact
  • Big Data

  • Data 10EB+. Tech Upgrade to handle next stage
  • Symposium

  • Aims to be the leading data provider in the industry
  • Pharma

  • Partnerships close with 10-20 companies
  • Technology

  • Upgrade to version 2.0 for scale and security

MediChain Team

geverifieerd 4%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Mark Baker
CEO and Founder
geverifieerde
Nicolas Smoll
Medical Doctor, Epidemiologist
geverifieerde
Samuel Dare
Blockchain Engineer
geverifieerde
Katy Blackwell
Team Manager
geverifieerde
Deepak Jha
Business Development and Token Purchaser Relations
geverifieerde
Giannis Stathopoulos
Business Development and Operations
geverifieerde
Naomi Ellis
PR Specialist and Designer
geverifieerde
Mark Shorter
Creative Director / UX Specialist and Designer
geverifieerde
Augustín Cassani
Blockchain Engineer
geverifieerde
Rob Moya
UX/UI Designer and Developer
geverifieerd
David Forbes
Software Developer
geverifieerde
Ron Cafferky
Electronic Health Records Specialist
geverifieerde
Raúl Van Riezen
Business Development & Finance
geverifieerde
Pedro Silva
Business Development
geverifieerde
Tim Akito Rei
Business Development - Japan
geverifieerde
Fred Fooks
Business Development
geverifieerde
Aizhan Seraly
Business Development
geverifieerde
Akhila Nandanavanam
Business Development
geverifieerde
Thomas Kang
Business Development
geverifieerde
Yuta Saitoh
Business Development
geverifieerde
Esther Lu
Business Development
geverifieerde
Rachael Edwards
Business Development & Marketing
geverifieerde
Skye Bye
HR Assistant
geverifieerde
Youli Pan
Business Development
geverifieerde
Yilin (Linda) Wen
Business Development
geverifieerde
Matt Ganeles
Business Development
geverifieerde

Advisors

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Chris Fennell
Advisor
geverifieerde

85 ICOs

$204 005 895

Simon Cocking
Advisor
geverifieerde

29 ICOs

$44 870 308

Amarpreet Singh
Advisor
geverifieerde

9 ICO

$119 505 765

Jon Matonis
Advisor
geverifieerde

8 ICO

$134 312 980

Keath Teare
Advisor
geverifieerde

4 ICO

$7 437 905

Mike Raitsyn
Advisor
geverifieerde

15 ICOs

$61 131 482

Simon Choi
Advisor
geverifieerde

11 ICOs

$30 450 330

Gabriel Zanko
Advisor
geverifieerde

12 ICOs

$21 218 786

Alex Linenko
Advisor
geverifieerde

9 ICO

$20 243 124

Andrey Korotkov
Advisor
geverifieerde

MediChain Interviews

Rob Moya
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
My dad has been a role model for me as a Costa Rican Physician who has proven that with a lot of effort you can achieve great things and I wanted to help save lives as he has done many times before, Medichain is trying to do this and more by using blockchain. I'm proud to be part of this project.

MediChain Laatste nieuws

N/A
5.0 16
ICO Profiel Visie Activiteit potentieel Artikel Team

% name% Reviews

thetechinsider.org
reviews

Summary

To conclude, MediChain is used to keep your medical records and data stored in one place. With blockchain, it keeps them privatized and secure from third-party hackers. Once this ICO makes their product and have a physical representation it, it could disrupt the medical industry and make it more efficient.

Positives
Decentralized Data Gathering: With MediChain, doctors, nurses, and other registered pharmaceuticals can use your data to help diagnose you and give you treatment based off your health history.
Smart Contracts: When using MediChain, smart contracts are made to give a limited time for medical experts to view the patient’s data.
Benefits all Medic Experts: MediChain provides benefits to doctors, insurers and pharmaceutical companies.

Negatives
Product Needed: We want to see a beta test of a MediChain to see if its product can work in a realistic environment.
Competition: How will MediChain can do well when placed against their competitors? Is their product innovative enough to get them the most market share?
Data Protection: While blockchain can be used to protect medical data, what will MediChain do if hacks occur and their data is compromised?

Lees verder
  • Omdat er mogelijk tijdsverschillen zijn in informatie-updates, moet nauwkeurige informatie over elk ICO-project worden geverifieerd via de officiële website of andere communicatiekanalen.
  • Deze informatie is geen suggestie of advies over beleggen in ICO-financiering. Onderzoek de relevante informatie zelf grondig en besluit over ICO-deelname.
  • Als u denkt dat er problemen of problemen zijn die moeten worden gecorrigeerd voor deze inhoud, of als u uw eigen ICO-project wilt indienen dat wordt vermeld, e-mail ons.
Lees de disclaimer en risicowaarschuwing. Laat disclaimer en risicowaarschuwing zien.